Spineology received FDA 510(k) clearance in July 2016 for use of allograft bone with Rampart™ Interbody Fusion Devices.
The clearance enables the pairing of allografts from the Musculoskeletal Transplant Foundation with the Rampart product line, and also serves as a delivery platform for Spineology’s Incite™ Cortical Fiber bone graft.
Rampart devices are supported by a recently-enhanced instrumentation system, and are available sterile packed.
Sources: Spineology Inc.; FDA.gov; ORTHOWORLD Inc.
Spineology received FDA 510(k) clearance in July 2016 for use of allograft bone with Rampart™ Interbody Fusion Devices.
The clearance enables the pairing of allografts from the Musculoskeletal Transplant Foundation with the Rampart product line, and also serves as a delivery platform for Spineology's Incite™ Cortical Fiber bone graft.
...
Spineology received FDA 510(k) clearance in July 2016 for use of allograft bone with Rampart™ Interbody Fusion Devices.
The clearance enables the pairing of allografts from the Musculoskeletal Transplant Foundation with the Rampart product line, and also serves as a delivery platform for Spineology’s Incite™ Cortical Fiber bone graft.
Rampart devices are supported by a recently-enhanced instrumentation system, and are available sterile packed.
Sources: Spineology Inc.; FDA.gov; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.